▲ 1.09%
prev close
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Congressional Trades
4
All tracked trades
Members Trading
3
Unique members
Net Activity
+0
2 buys · 2 sells
Members Who Traded This Stock
4 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-12-29 | IQVIQVIA Holdings Inc. | Buy | $15,001 - $50,000 | 76d ago | — | |
| 2025-10-02 | IQVIQVIA Holdings Inc. | Sell | $1,001 - $15,000 | 138d ago | — | |
| 2025-05-15 | IQVIQVIA Holdings Inc. | Sell | $1,001 - $15,000 | 306d ago | — | |
| 2025-04-08 | IQVIQVIA Holdings Inc. | Buy | $15,001 - $50,000 | 329d ago | — |
2025-12-29
Markwayne Mullin
IQV
Amount
$15,001 - $50,000
Filed
76d ago
2025-10-02
John Boozman
IQV
Amount
$1,001 - $15,000
Filed
138d ago
2025-05-15
Rob Bresnahan
IQV
Amount
$1,001 - $15,000
Filed
306d ago
2025-04-08
Rob Bresnahan
IQV
Amount
$15,001 - $50,000
Filed
329d ago
Recent News
Powered by Polygon.io
Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans
Pharmacovigilance Market Size to Reach USD 24.69 Billion by 2035 Owing to the Surging Demand for Drug Safety Monitoring Solutions Globally
Clinical Trials Support Software Solutions in a $34.15B Trial Economy by 2035
Real-World Data on Healthcare Technology Adoption: Company Insights and Government Trends with Key Statistics (e.g., 71% U.S. Hospitals Adoption, $3B Company Valuations)
Why Clinical Data Analytics Is Becoming One of Healthcare’s Fastest-Growing Markets?
Trade Timeline
Congressional activity, newest first
Markwayne Mullin
2025-12-29 · Purchase
$15,001 - $50,000
John Boozman
2025-10-02 · Sale
$1,001 - $15,000
Rob Bresnahan
2025-05-15 · Sale
$1,001 - $15,000
Rob Bresnahan
2025-04-08 · Purchase
$15,001 - $50,000